Publications by authors named "Yi M Cui"

Claim this Profile
T
The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.
Xiao Cong Pang, Han Xu Zhang, Zhi Zhang, Suguro Rinkiko, Yi Min Cui

Molecules· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study.
Xia Zhao, Xiao Yan Sheng, Christopher D Payne, Xin Zhang, Feng Wang, Yi Min Cui

Clin Pharmacol Drug Dev· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and tolerability of single- and multiple-dose exenatide once weekly in Chinese patients with type 2 diabetes mellitus.
Yi Min Cui, Xiao Hui Guo, Dong Mei Zhang, Lai San Tham, Cheng Cai Tang

J Diabetes· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Influence of MDR1 G2677T/a genetic polymorphisms on the pharmacokinetics of repaglinide in healthy Chinese volunteers.
Qian Xiang, Yi Min Cui, Xia Zhao, Liang Yan, Ying Zhou

Pharmacology· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of CYP2D6, CYP3A5, and MDR1 genetic polymorphisms on the pharmacokinetics of risperidone and its active moiety.
Qian Xiang, Xia Zhao, Ying Zhou, Jing Li Duan, Yi Min Cui

J Clin Pharmacol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 allele.
Yi M Cui, Choo H Teng, Alan X Pan, Eunice Yuen, Kwee P Yeo

Br J Clin Pharmacol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis